Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Avacopan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 166,094Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amgen's ChemoCentryx Wins Investor Lawsuit
    Amgen's ChemoCentryx Wins Investor Lawsuit

    19 Aug 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/amgens-chemocentryx-prevails-investor-lawsuit-around-autoimmune-drug-tavneos

    FIERCE PHARMA
    19 Aug 2025
    Share Share
    Lawsuit Points to Alleged Misconduct at Amgen-Bought Biotech
    Lawsuit Points to Alleged Misconduct at Amgen-Bought Biotech

    25 Jul 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/doctored-data-protest-trial-observers-new-evidence-points-alleged-misconduct-amgen-bought

    FIERCE PHARMA
    25 Jul 2025
    Share Share
    Vifor's Tavneos (avacopan) Receives Approval in Europe
    Vifor's Tavneos (avacopan) Receives Approval in Europe

    19 Jul 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/tavneos-epar-medicine-overview_en.pdf

    EMA
    19 Jul 2023
    Share Share
    Tavneos included in updated EULAR recommendations for the management of AAV
    Tavneos included in updated EULAR recommendations for the management of AAV

    27 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tavneos-avacopan-included-in-updated-eular-recommendations-for-the-management-of-aav-301782385.html

    PR NEWSWIRE
    27 Mar 2023
    Share Share
    Vifor Pharma's Tavneos (Avacopan) Approved In Europe
    Vifor Pharma's Tavneos (Avacopan) Approved In Europe

    13 Feb 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/tavneos-epar-medicine-overview_en.pdf

    EMA
    13 Feb 2023
    Share Share
    Vifor's Tavneos (Avacopan) Receives Approval in the Europe
    Vifor's Tavneos (Avacopan) Receives Approval in the Europe

    25 Nov 2022

    // EMA

    https://www.ema.europa.eu/en/documents/overview/tavneos-epar-medicine-overview_en.pdf

    EMA
    25 Nov 2022
    Share Share